Login / Signup

Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment.

Sicong HuangVanessa L KronzerPaul F DellaripaKevin D DeaneMarcy B BolsterVivek NagarajaDinesh KhannaTracy J DoyleJeffrey A Sparks
Published in: Current treatment options in rheumatology (2020)
RA-ILD is an underrecognized and serious manifestation of RA, but important progress is being made in identifying risk factors and treatment.
Keyphrases
  • interstitial lung disease
  • rheumatoid arthritis
  • risk factors
  • systemic sclerosis
  • disease activity
  • idiopathic pulmonary fibrosis
  • ankylosing spondylitis
  • systemic lupus erythematosus